A Polymeric Protein Induces Specific Cytotoxicity in a TLR4 Dependent Manner in the Absence of Adjuvants

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Berguer, Paula M ^a   Alzogaray, Vanina A ^a   Rossi, Andrés Hugo ^a   Mundiñano, Juliana ^b   Piazzon, Isabel ^b   Goldbaum, Fernando A ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HERMES ANTIGEN; INTERLEUKIN 7 RECEPTOR ALPHA; LUMAZINE SYNTHASE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DENDRITIC CELL; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PROTEIN DENATURATION; PROTEIN EXPRESSION; PURIFICATION; SIGNAL TRANSDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOPOLYMERS; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; CYTOTOXICITY, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENT DYES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MULTIENZYME COMPLEXES; OVALBUMIN; POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 4;

BRUCELLA; MUS;

EID: 84866719309     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045705     Document Type: Article

References (59)

1. Heath WR, Carbone FR, (2001) Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19: 47-64.
2. Yewdell JW, Norbury CC, Bennink JR, (1999) Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol 73: 1-77.
3. Reimann J, Schirmbeck R, (1999) Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation. Immunol Rev 172: 131-152.
4. Freigang S, Eschli B, Harris N, Geuking M, Quirin K, et al. (2007) A lymphocytic choriomeningitis virus glycoprotein variant that is retained in the endoplasmic reticulum efficiently cross-primes CD8(+) T cell responses. Proc Natl Acad Sci U S A 104: 13426-13431.
5. Buseyne F, Le Gall S, Boccaccio C, Abastado JP, Lifson JD, et al. (2001) MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat Med 7: 344-349.
6. Schirmbeck R, Bohm W, Reimann J, (1996) Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology 39: 111-119.
7. Jondal M, Schirmbeck R, Reimann J, (1996) MHC class I-restricted CTL responses to exogenous antigens. Immunity 5: 295-302.
8. Ackerman AL, Kyritsis C, Tampé R, Cresswell P, (2005) Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells. Nat Immunol 6: 107-113.
9. Basta S, Stoessel R, Basler M, van den Broek M, Groettrup M, (2005) Cross-presentation of the long-lived lymphocytic choriomeningitis virus nucleoprotein does not require neosynthesis and is enhanced via heat shock proteins. J Immunol 175: 796-805.
10. Wolkers MC, Brouwenstijn N, Bakker AH, Toebes M, Schumacher TN, (2004) Antigen bias in T cell cross-priming. Science 304: 1314-1317.
11. Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, et al. (2004) CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304: 1318-1321.
12. Shen L, Rock KL, (2004) Cellular protein is the source of cross-priming antigen in vivo. Proc Natl Acad Sci U S A 101: 3035-3040.
13. Tsan MF, Gao B, (2009) Heat shock proteins and immune system. J Leukoc Biol 85: 905-910.
14. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, et al. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13: 1050-1059.
15. Cho HJ, Takabayashi K, Cheng PM, Nguyen MD, Corr M, et al. (2000) Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat Biotechnol 18: 509-514.
16. Heit A, Schmitz F, O'Keeffe M, Staib C, Busch DH, et al. (2005) Protective CD8 T cell immunity triggered by CpG-protein conjugates competes with the efficacy of live vaccines. J Immunol 174: 4373-4380.
17. Schirmbeck R, Riedl P, Zurbriggen R, Akira S, Reimann J, (2003) Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cells. J Immunol 171: 5198-5207.
18. Wille-Reece U, Flynn BJ, Lore K, Koup RA, Kedl RM, et al. (2005) HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc Natl Acad Sci U S A 102: 15190-15194.
19. Storni T, Ruedl C, Schwarz K, Schwendener RA, Renner WA, et al. (2004) Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects. J Immunol 172: 1777-1785.
20. Weck MM, Grunebach F, Werth D, Sinzger C, Bringmann A, et al. (2007) TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109: 3890-3894.
21. Baldi PC, Giambartolomei GH, Goldbaum FA, Abdon LF, Velikovsky CA, et al. (1996) Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol 3: 472-476.
22. Goldbaum FA, Leoni J, Wallach JC, Fossati CA, (1993) Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 31: 2141-2145.
23. Velikovsky CA, Goldbaum FA, Cassataro J, Estein S, Bowden RA, et al. (2003) Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun 71: 5750-5755.
24. Velikovsky CA, Cassataro J, Giambartolomei GH, Goldbaum FA, Estein S, et al. (2002) A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 70: 2507-2511.
25. Sciutto E, Toledo A, Cruz C, Rosas G, Meneses G, et al. (2005) Brucella spp. lumazine synthase: a novel antigen delivery system. Vaccine 23: 2784-2790.
26. Bellido D, Craig PO, Mozgovoj MV, Gonzalez DD, Wigdorovitz A, et al. (2009) Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system. Vaccine 27: 136-145.
27. Velikovsky CA, Cassataro J, Sanchez M, Fossati CA, Fainboim L, et al. (2000) Single-shot plasmid DNA intrasplenic immunization for the production of monoclonal antibodies. Persistent expression of DNA. J Immunol Methods 244: 1-7.
28. Laplagne DA, Zylberman V, Ainciart N, Steward MW, Sciutto E, et al. (2004) Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides. Proteins 57: 820-828.
29. Craig PO, Berguer PM, Ainciart N, Zylberman V, Thomas MG, et al. (2005) Multiple display of a protein domain on a bacterial polymeric scaffold. Proteins 61: 1089-1100.
30. Braden BC, Velikovsky CA, Cauerhff AA, Polikarpov I, Goldbaum FA, (2000) Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus. J Mol Biol 297: 1031-1036.
31. Zylberman V, Craig PO, Klinke S, Braden BC, Cauerhff A, et al. (2004) High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase. J Biol Chem 279: 8093-8101.
32. Berguer PM, Mundiñano J, Piazzon I, Goldbaum FA, (2006) A polymeric bacterial protein activates dendritic cells via TLR4. J Immunol 176: 2366-2372.
33. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, et al. (1994) T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
34. Institute of Laboratory Animal Resources (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington DC.
35. Goldbaum FA, Velikovsky CA, Baldi PC, Mortl S, Bacher A, et al. (1999) The 18-kDa cytoplasmic protein of Brucella species -an antigen useful for diagnosis-is a lumazine synthase. J Med Microbiol 48: 833-839.
36. Lyons AB, (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243: 147-154.
37. Nelson D, Bundell C, Robinson B, (2000) In vivo cross-presentation of a soluble protein antigen: kinetics, distribution, and generation of effector CTL recognizing dominant and subdominant epitopes. J Immunol 165: 6123-6132.
38. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT, (2003) CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198: 889-901.
39. Shaw CA, Starnbach MN, (2008) Antigen delivered by anthrax lethal toxin induces the development of memory CD8+ T cells that can be rapidly boosted and display effector functions. Infect Immun 76: 1214-1222.
40. Huster KM, Busch V, Schiemann M, Linkemann K, Kerksiek KM, et al. (2004) Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. Proc Natl Acad Sci U S A 101: 5610-5615.
41. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4: 1191-1198.
42. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4: 225-234.
43. Schluns KS, Lefrancois L, (2003) Cytokine control of memory T-cell development and survival. Nat Rev Immunol 3: 269-279.
44. Meruelo D, Offer M, Rossomando A, (1982) Evidence for a major cluster of lymphocyte differentiation antigens on murine chromosome 2. Proc Natl Acad Sci U S A 79: 7460-7464.
45. Havran WL, Lancki DW, Moldwin RL, Dialynas DP, Fitch FW, (1988) Characterization of an anti-Ly-6 monoclonal antibody which defines and activates cytolytic T lymphocytes. J Immunol 140: 1034-1042.
46. Fierer J, Walls L, Kirkland TN, (2000) Genetic evidence for the role of the Lv locus in early susceptibility but not IL-10 synthesis in experimental coccidioidomycosis in C57BL mice. J Infect Dis 181: 681-685.
47. Cox MA, Zajac AJ, (2010) Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection. J Biomed Biotechnol DOI:10.1155/2010/159152.
48. Sanchez PJ, Kedl RM, (2012) An alternative signal 3: CD8+ T cell memory independent of IL-12 and type I IFN is dependent on CD27/OX40 signaling. Vaccine 30: 1154-1161.
49. Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med 194: 769-779.
50. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, et al. (2002) Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196: 1627-1638.
51. Takeda K, Kaisho T, Akira S, (2003) Toll-like receptors. Annu Rev Immunol 21: 335-376.
52. Blander JM, Medzhitov R, (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304: 1014-1018.
53. Blander JM, Medzhitov R, (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
54. Yarovinsky F, Kanzler H, Hieny S, Coffman RL, Sher A, (2006) Toll-like receptor recognition regulates immunodominance in an antimicrobial CD4+ T cell response. Immunity 25: 655-664.
55. Keller SA, Schwarz K, Manolova V, von Allmen CE, Kinzler MG, et al. (2010) Innate signaling regulates cross-priming at the level of DC licensing and not antigen presentation. Eur J Immunol 40: 103-112.
56. Oh JZ, Kedl RM, (2010) The capacity to induce cross-presentation dictates the success of a TLR7 agonist-conjugate vaccine for eliciting cellular immunity. J Immunol 185: 4602-4608.
57. Koniaras C, Bennett SR, Carbone FR, Heath WR, Lew AM, (1997) Peptide-induced deletion of CD8 T cells in vivo occurs via apoptosis in situ. Int Immunol 9: 1601-1605.
58. Schott E, Bertho N, Ge Q, Maurice MM, Ploegh HL, (2002) Class I negative CD8 T cells reveal the confounding role of peptide-transfer onto CD8 T cells stimulated with soluble H2-Kb molecules. Proc Natl Acad Sci U S A 99: 13735-13740.
59. Bijker MS, van den Eeden SJ, Franken KL, Melief CJ, Offringa R, et al. (2007) CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity. J Immunol 179: 5033-5040.